bioRxivNeurosciencePreprint
Therapeutic window for treatment of prion disease defined by timed depletion of Prion protein
Barry Matthew BradfordiD, Alison Marshall, Nadia L. Tuzi, Deborah Brown, Dorothy KisielewskiiD, KIM M. SUMMERSiD, Victor Hugh PerryiD, Pedro Piccardo, Alan Richard ClarkeiD, Jean C. MansoniD
Abstract
There is no effective treatment preventing the progression of neurodegenerative diseases such as prion and Alzheimers diseases. These fatal diseases of the central nervous system, involve progressive accumulation of a misfolded protein long before overt clinical signs of disease. Removal of prion protein early in the pathological process appears to halt the progression however, it is not known whether intervention at later disease stages could be effective. We investigated the potential for intervention throughout the course of prion disease, by developing a mouse model in which Prnp expression can be manipulated in a tissue specific and time dependent manner. Depleting Prnp from neuronal populations in CNS throughout the preclinical phase substantially prolonged incubation. The pathology was dramatically altered to a pattern of astrocytic associated prion deposition. However once overt clinical symptoms of disease were apparent Prnp depletion did not alter disease progression. This study establishes a wide window for intervention, and suggests timely treatment could delay the onset of clinical disease potentially well beyond the lifetime of an individual.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PrP turnover in vivo and the time to effect of prion disease therapeutics
Taylor L Corridon, Jill O’Moore, … Eric Vallabh Minikel·PLoS PathogensPeer-reviewed·May 26, 2026
- Prevention of prion disease symptoms in mice with deep PrP lowering
Juliana E Gentile, Jonathan E. Farley, … Eric Vallabh Minikel·bioRxiv·Oct 24, 2026
- Prion protein lowering is a disease-modifying therapy across prion strains, disease stages, and endpoints
Eric Vallabh Minikel, Hien Tran Zhao, … Sonia M. Vallabh·Nucleic Acids ResearchPeer-reviewed·Jul 13, 2020
- Targeting neuroinflammation by pharmacologic down-regulation of inflammatory pathways is neuroprotective in protein misfolding disorders.
Sydney J. Risen, Sean W. Boland, … Julie A. Moreno·ACS Chemical NeurosciencePeer-reviewed·Mar 20, 2024
- Anti-prion drugs do not improve survival in knock-in models of inherited prion disease
D. Walsh, J. Rees, … S. Supattapone·bioRxiv·Sep 28, 2023
- Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection
P. Aguilar Calvo, A. Malik, … C. J. Sigurdson·bioRxiv·Jun 19, 2023